United States· US:0574-0292_416c3aaf-7390-40cf-995a-31258156b4f2
amiloride hydrochloride
A amiloride product containing amiloride hydrochloride, registered in United States by Padagis US LLC. The same ATC class is registered in 5 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Amiloride is registered in 5 of 19 countries.
Countries holding a registration under ATC C03DB01 (amiloride), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Amiloride · ATC C03DB01
5 / 19 countries
- Canada
- Finlandprice
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AMILORIDE HYDROCHLORIDE
- Manufacturer
- Padagis US LLC
- Country
- United States (US)
- ATC code
- C03DB01
- ATC class
- Amiloride
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110574029201100 TABLET in 1 BOTTLE (0574-0292-01)
- ndc110574-0292-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
238 interactions on record for amiloride.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amiloride · interactions on record
238 records
- 7 severe
- 115 moderate
- 7 minor
- 32 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
77 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Amiloride in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAmiloride 5mg tabletsTeva UK Ltd
- NorwayAmiloride padagisPadagis
- CanadaMIDAMORAA PHARMA INC
- FinlandMedamorMerck Sharp & Dohme B.V.
- FranceMODAMIDE 5 mg, compriméSUBSTIPHARM
- BelgiumFrusamil 5 mg - 40 mgSanofi Belgium
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Cyprus · Alverix, Amiloride Accord Healthcare
- France · Modamide
- United Kingdom (Northern Ireland) · Amiloride, Amiloride Accord Healthcare
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee449339-e256-49ae-87bc-a0785f661104 GET /v1/drugs/ee449339-e256-49ae-87bc-a0785f661104?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "AMILORIDE HYDROCHLORIDE",
"productndc": "0574-0292",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA018200",
"marketing_category": "NDA AUTHORIZED GENERIC"
}See everything about amiloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.